Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Suzanne Maynard"'
Autor:
Suzanne Maynard, Jose Ros-Soto, Aris Chaidos, Andrew Innes, Krushika Paleja, Eitan Mirvis, Noora Buti, Harriet Sharp, Renuka Palanicawandar, Dragana Milojkovic
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 274-276 (2021)
Immune modulation in COVID-19 is emerging as an important therapeutic strategy as increasing evidence suggests that inflammatory pathways are implicated in lung damage. Bruton tyrosine kinase inhibitors (BTKi), such as ibrutinib, are commonly used to
Externí odkaz:
https://doaj.org/article/85d83e5aadde42838aab0d9702e47654
Autor:
Yao Jiang, Jennifer M. Down, Suzanne Maynard, Sian Jenkins, Lauren Ferritti, Flavio Beke, Bader Al-Hazmi, Andrew D. Southam, Jouni Kvist, Leda Mirbahai, Lenka Besse, Chris M. Bunce, Mark T. Drayson, Michelle A. Lawson, Farhat Khanim
Background Renal impairment (RI) caused by deposition of Multiple myeloma (MM) derived free light chains (FLC), is associated with worse MM patient outcomes. Reciprocally, early reduction of serum-FLC improves survival. Proteasome inhibitors (PIs), w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c584822c630c2e2153e4de48e2b372cf
https://doi.org/10.21203/rs.3.rs-2520124/v1
https://doi.org/10.21203/rs.3.rs-2520124/v1
Autor:
Noora Buti, Eitan Mirvis, Aris Chaidos, Suzanne Maynard, Krushika Paleja, Andrew J. Innes, Dragana Milojkovic, Renuka Palanicawandar, Jose Ros-Soto, Harriet Sharp
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 274-276 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 274-276 (2021)
Immune modulation in COVID-19 is emerging as an important therapeutic strategy as increasing evidence suggests that inflammatory pathways are implicated in lung damage. Bruton tyrosine kinase inhibitors (BTKi), such as ibrutinib, are commonly used to
Publikováno v:
British Journal of Haematology. 199:637-637